Medicines systems: Convergence for access Dr Socorro Escalante WHO Country Office for Viet Nam 1.

Slides:



Advertisements
Similar presentations
Saul Walker Policy and Research Division, DFID Jordan 4 December, 2007 Medicines Transparency Alliance (MeTA)
Advertisements

Regulation of Pharmaceutical Promotion: assessment, analysis & advocacy Lilia Ziganshina 20 May 2009 WHA.
Strategies to Improve Efficiency in Medicine Procurement Towards equitable and affordable medicine prices policies in Jordan Workshop 4-5 Dec, 2007 Dr.
Scaling up the global initiative on the implementation of the SNA and supporting statistics Meeting on Scaling up the coordination and resources for the.
The WHO Medicines Strategy Richard Laing Based on materials produced by Hans V. Hogerzeil, Essential Medicines and Pharmaceutical Policies November.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Governance for REDD+ Crystal Davis Governance of Forests Initiative World Resources Institute REDD Civil Society Coordination Seminar CIFOR campus, Bogor.
Building Grassroots Capacity for Policy Feedback in Nepal Krishna Lamsal Programme Officer, LI-BIRD.
Making the UN “fit for purpose” for the new sustainable development agenda John Hendra December 2014.
Uganda Child Protection Sub Cluster Transition: Experiences & Reflections Presented by: Agnes M.Wasike National Coordinator – CPWG.
Implementation of TRIPS Flexibilities in National IP Legislation for Strengthening Access to Medicines in Seychelles.
Operationalising Carbon Finance in Ghana. Roundtable Meeting November 2008 The Role of Governance and Institutions in REDD Operationalising Carbon.
Presented to CSO workshops in Kabwe on 18 July 2014, Livingstone on 28 July 2014 and Lusaka on 27 August 2014.
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
Medicines Transparency Alliance Presented by Deirdre Dimancesco Department of Essential Medicines and Health Products, WHO at the Technical Briefing Seminar.
FORMATION OF THE GHANA MeTA CIVIL SOCIETY NETWORK : AN OVERVIEW 1 Allotey. C; 2 Ahiabu. R.K.A; 3 Ntoso. R.Y; 4 Azumah. S.K; 5 Andoh.I 1,5. Health Access.
CARICOM TRAINING PROGRAMME FOR SENIOR OFFICERS. CARICOM Content of Presentation Elements of Training Programme Implementation modalities and Results achieved.
Presentation on Managing for Development Results in Zambia By A. Musunga Director M&E MOFNP - Zambia.
MeTA Jordan Executive Summary Baseline data is an important source for policy makers to diagnose the pharmaceutical and health sector situation in order.
Successful strategies for supporting regional FLEG declarations Regional Conference on ”Update on the 2005 Saint Petersburg Ministerial Declaration” Tbilisi,
Medicines Transparency Alliance13/09/ MeTA Uganda Country Overview Public Sector Private Sector Civil Society.
MULTI-STAKEHOLDER COLLABORATION: CAN IT IMPROVE TRANSPARENCY, DISCLOSURE AND ACCESS TO MEDICINES? EXPERIENCES FROM 7 META PILOT COUNTRIES Wilbert Bannenberg.
Regional Centers for Results Based Management and Evaluation Capacity Development: Regional Centers for Results Based Management and Evaluation Capacity.
Wilbert Bannenberg, Technical Director MeTA International Secretariat IACC 14 Bangkok, 13 November 2010 MeTA multi-stakeholder process – a way to improve.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Medicines Transparency Alliance03/10/ MeTA Zambia Violet Kabwe MeTA Zambia Consultant.
1.Resourcing the response to climate change is a global challenge. 2.The proposed framework will develop evidence, and structure lesson learning, within.
A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE Annual General Meeting Working group sessions Annual General Meeting Working group sessions.
Creating a shared vision for CSI in Namibia. CSFN Vision & Mission  Vision: A strong Namibia & a strong civil society with a secure financial foundation.
SECTOR-WIDE APPROACH – a Planning Tool for Samoa Ms. Makerita Luatimu – Tiotio (Public Administration Sector Coordinator) Mr. Talatalaga Matau – (ACEO:
Contact Monitoring Regional Network (CMKN). Why procurement It is estimated that an effective public procurement system could save as much as 25% of government.
16 May 2008 Hon Francisco T. Duque Secretary Department of Health MeTA Philippines: Sharing Responsibility, Achieving as One MeTA1.
1 Towards a Medicines Transparency Alliance (MeTA) Richard Laing and Ali Cameron with slides prepared by Michael Borowitz, DfID WHO Technical Briefing.
Medicines Transparency Alliance - Zambia Billy Mweetwa Country Medicines Advisor – Zambia.
Medicines Transparency Alliance27/10/ MeTA Ghana Augustina Koduah (Mrs) Country Coordinator.
MeTA Medicines Transparency Alliance: Under New Management Dr Tim Reed Director, Health Action International (Global) International MeTA Secretariat.
META PHILIPPINES WORKPLAN : EARLY ACCOMPLISHMENTS IN THE PILOT PHASE.
SARPAM Southern African Regional Programme for Access to Medicines and Diagnostics Presentation to Botswana TRIPS and Access to Medicines workshop 26 March.
Medicines Transparency Alliance Presented by Gilles Forte Department of Essential Medicines and Health Products, WHO On behalf of WHO and HAI Technical.
SOUTHERN AFRICAN REGIONAL PROGRAMME ON ACCESS TO MEDICINES AND DIAGNOSTICS PROCESS & CHALLENGES OF WORKING REGIONALLY IN SOUTHERN AFRICA AARTI PATEL WHO.
Open Discussion on : Future Development of HIA in ASEAN Community 1 st HIA for ASEAN Workshop “Understanding HIA : A Foundation for the Well-being of the.
Medicines Transparency Alliance18/12/ Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator.
Project 4 Ensuring Coordination, Evidence Based Programming, and Monitoring of the Peacebuilding Fund Projects in Uganda.
Observatories for the Health Workforce in Africa VIII REGIONAL MEETING OF THE OBSERVATORIES OF HUMAN RESOURCES FOR HEALTH IN THE AMERICAS LIMA, PERU
Roadmap & Actions Expert Consultation Health in All Policies.
DRAFT TOR FOR HUMAN RESOURCE FOR HEALTH GROUP. Background  HRH are important for improving quality of health care  HRHG is required to response the.
1 Sequenced Information Strategy –incorporating short-term programme proposal Paris21 Consortium meeting : June 2000 Tony Williams UK Department.
Medicines Transparency Alliance31/01/ MeTA Uganda Jacqueline Idusso Secretariat Coordinator.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
Findings From the National Preparations For Rio + 20 for Select Developing Countries A UNDESA/UNDP partnership International Workshop on Strengthening.
Elaine Ireland Global Health Advocacy Officer, International HIV/AIDS Alliance Rome, 9 th February Delivering Effective Aid for Health: International Health.
Wilbert Bannenberg & Elodie Brandamir Technical & Operational Directors MeTA International Secretariat MeTA Kyrgyzstan Forum Bishkek, 16 April 2009 Medicines.
Wilbert Bannenberg Technical Director, Intl MeTA Secretariat 28 April 2010, IPC meeting, Copenhagen Medicines Transparency Alliance: improving people’s.
Proposed Process for Development of a Health Research Agenda in Kenya Dr. Charles M. Nzioka, Head, DHR&D Ministry of Health 21 st June 2014.
CDP-GIZ research project – Paris Workshop Gesellschaft für internationale Zusammenarbeit GmbH André Lammerding, Head of Programme International Water Stewardship.
Medicines Transparency Alliance12/06/ MeTA Peru Germán Rojas, Technical Secretary Leda M. Perez, Consultant to MeTA in Peru.
The Medicines Transparency Alliance Saul Walker Senior Policy Advisor, Access to Medicines Health Services Team.
Coordination and Partnerships of SDG4-Education 2030 Le Thu Huong Section of Partnerships, Cooperation and Research, UNESCO Paris.
Access to Information, Participation in Decision-Making and Justice in the OECS: some thoughts Peter A. Murray OECS Secretariat.
WHO’s prioritised research agenda for the prevention and control of NCDs prioritises
WHO Medicines Work in Countries: The Kenya Example
GLOBAL PREVENTION COALITION
THE FUTURE EVOLUTION OF CIVIL SOCIETY IN THE EUROPEAN UNION BY 2030
Setting UP Multi Stakeholder Processes for responsible land governance
MeTA Philippines Roberto M. Pagdanganan
Peter Chibatamoto HIV/AIDS Policy Advisor
Social Determinants of Health
Implementing the 2030 Agenda in the Asia- Pacific region, January 2019, Shanghai Institutional arrangements to facilitate coherence in sustainable.
CAPACITY DEVELOPMENT FOR DEVELOPMENT EFFECTIVENESS FACILITY FOR ASIA AND PACIFIC A framework for promoting lesson learning on the use of country systems.
Presentation transcript:

Medicines systems: Convergence for access Dr Socorro Escalante WHO Country Office for Viet Nam 1

The goal of a national medicines systems remains to be availability, affordability, rational use and access to: Quality assured, safe, efficacious and affordable medicines 1

Medicines Systems 3 Access to Medicines Pharmaceutical Sector Public health needs and societal value Stewardship Government and Society The National Pharmaceutical Strategy Pharmaceutical Law

Translating the strategy and law into the medicines system 4

5 Source: Medicines in Health Systems, WHO and Alliance for Policy and Systems Research, 2014

Broad areas for collaboration 1. Policy development 2. Building capacity of institutions 3. Generating evidence 4.Governance, transparency and accountability 5.Innovation 6

Mechanisms of Collaboration The Technical Working Group on Pharmaceuticals Technical arm of the HPG Technical support for policy making and programme implementation Coordination of activities and support 7

Mechanisms of Collaboration The MeTA Model MeTA stands for Medicines Transparency Alliance Focus on improving transparency and governance in the pharmaceutical sector Multi-stakeholder engagement among government, industry and civil society Countries involved: Ghana, Kyrgyzstan, Jordan, Peru, Philippines, Uganda and Zambia Funded by DFID Current Secretariat: WHO and Health Action International (HAI) 8

Way forward Immediate: 1.Consultation process on the pharmaceutical law: consultations will be organized and HPG members will be called upon to participate Medium and longer-term: 1.Revisit the TWG (TOR and operationalize) for a coordinated DP support in the implementation of the Strategy and the Law 2.Explore other mechanisms to tackle broader and multi- sectoral issues 9

Thank you 1